12/1
08:30 am
lenz
LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia
Low
Report
LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia
11/25
04:56 pm
lenz
LENZ Therapeutics to Present at Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
LENZ Therapeutics to Present at Upcoming Investor Conferences [Yahoo! Finance]
11/25
04:05 pm
lenz
LENZ Therapeutics to Present at Upcoming Investor Conferences
Low
Report
LENZ Therapeutics to Present at Upcoming Investor Conferences
11/22
07:57 am
lenz
LENZ Therapeutics (NASDAQ:LENZ) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
LENZ Therapeutics (NASDAQ:LENZ) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
11/12
05:45 am
lenz
Insider Spends US$239k Buying More Shares In LENZ Therapeutics [Yahoo! Finance]
Medium
Report
Insider Spends US$239k Buying More Shares In LENZ Therapeutics [Yahoo! Finance]
11/8
08:43 am
lenz
Analysts Are Upgrading LENZ Therapeutics, Inc. (NASDAQ:LENZ) After Its Latest Results [Yahoo! Finance]
Low
Report
Analysts Are Upgrading LENZ Therapeutics, Inc. (NASDAQ:LENZ) After Its Latest Results [Yahoo! Finance]
11/7
07:58 am
lenz
Growth Opportunities in the United States' $7+ Billion Ophthalmic Eye Droppers Market, 2025-2033 [Yahoo! Finance]
Low
Report
Growth Opportunities in the United States' $7+ Billion Ophthalmic Eye Droppers Market, 2025-2033 [Yahoo! Finance]
11/5
08:00 am
lenz
LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
High
Report
LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
10/29
08:00 am
lenz
LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025
Medium
Report
LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025
10/27
10:07 am
lenz
LENZ Therapeutics (NASDAQ:LENZ) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
LENZ Therapeutics (NASDAQ:LENZ) had its "buy" rating reaffirmed by analysts at HC Wainwright.
10/24
05:33 am
lenz
LENZ Therapeutics (NASDAQ:LENZ) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
LENZ Therapeutics (NASDAQ:LENZ) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
10/20
01:28 pm
lenz
LENZ Therapeutics (NASDAQ:LENZ) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $50.00 price target on the stock, up previously from $40.00.
Low
Report
LENZ Therapeutics (NASDAQ:LENZ) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $50.00 price target on the stock, up previously from $40.00.
10/10
07:19 am
lenz
LENZ Therapeutics (NASDAQ:LENZ) was given a new $67.00 price target on by analysts at Piper Sandler.
High
Report
LENZ Therapeutics (NASDAQ:LENZ) was given a new $67.00 price target on by analysts at Piper Sandler.
10/1
07:47 am
lenz
Companies Like LENZ Therapeutics (NASDAQ:LENZ) Can Afford To Invest In Growth [Yahoo! Finance]
Low
Report
Companies Like LENZ Therapeutics (NASDAQ:LENZ) Can Afford To Invest In Growth [Yahoo! Finance]
9/30
08:13 am
lenz
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States [Yahoo! Finance]
Low
Report
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States [Yahoo! Finance]
9/30
08:05 am
lenz
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
Low
Report
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
9/30
08:00 am
lenz
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
Low
Report
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
9/22
04:07 am
lenz
Jim Cramer Says “LENZ Therapeutics Has a Promising Story” [Yahoo! Finance]
Medium
Report
Jim Cramer Says “LENZ Therapeutics Has a Promising Story” [Yahoo! Finance]
9/18
08:00 pm
lenz
Jim Cramer shares his bull case for Lenz Therapeutics [CNBC]
Low
Report
Jim Cramer shares his bull case for Lenz Therapeutics [CNBC]